GB8813144D0
(en)
*
|
1988-06-03 |
1988-07-06 |
Nycomed As |
Compositions
|
US6001335A
(en)
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US5580575A
(en)
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US5469854A
(en)
*
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US5705187A
(en)
|
1989-12-22 |
1998-01-06 |
Imarx Pharmaceutical Corp. |
Compositions of lipids and stabilizing materials
|
US5088499A
(en)
*
|
1989-12-22 |
1992-02-18 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
US5123414A
(en)
*
|
1989-12-22 |
1992-06-23 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
US5656211A
(en)
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
US5352435A
(en)
*
|
1989-12-22 |
1994-10-04 |
Unger Evan C |
Ionophore containing liposomes for ultrasound imaging
|
US5334381A
(en)
*
|
1989-12-22 |
1994-08-02 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
US5733572A
(en)
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
US5305757A
(en)
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US5773024A
(en)
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5230882A
(en)
*
|
1989-12-22 |
1993-07-27 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5149319A
(en)
*
|
1990-09-11 |
1992-09-22 |
Unger Evan C |
Methods for providing localized therapeutic heat to biological tissues and fluids
|
US5874062A
(en)
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US5385719A
(en)
*
|
1991-09-24 |
1995-01-31 |
Unger; Evan C. |
Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
|
EP1104678A2
(fr)
|
1992-05-04 |
2001-06-06 |
UNGER, Evan C |
Méthode de potention hypothermique de tissue
|
US5736121A
(en)
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
DE19500665A1
(de)
*
|
1995-01-12 |
1996-07-18 |
Axel Prof Dr Haase |
Verfahren zur ortsauflösenden Abbildung eines Bereiches eines biologischen Objektes mit Hilfe elektromagnetischer Strahlen unter Applikation von Kontrastmittel
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
US6033645A
(en)
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
WO1997040679A1
(fr)
|
1996-05-01 |
1997-11-06 |
Imarx Pharmaceutical Corp. |
Procedes d'apport de composes dans une cellule
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
US6143276A
(en)
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
US6123923A
(en)
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
JP2000086538A
(ja)
*
|
1998-09-17 |
2000-03-28 |
Toshihiro Akaike |
Mri用造影剤
|
IL151128A0
(en)
|
2000-02-08 |
2003-04-10 |
Rice University |
Optically-active nanoparticles for use in therapeutic and diagnostic methods
|
NZ529347A
(en)
|
2001-04-04 |
2008-01-31 |
Nordic Vaccine Technology As |
Use of at least one sterol capable of interacting with a nucleic acid and at least saponin to form immunostimulating complexes ( IMSCO )
|
EP3357490A1
(fr)
|
2006-04-28 |
2018-08-08 |
Children's Hospital Medical Center |
Propriétés fusogènes de la saposine c et de protéines et de polypeptides apparentés pour une application à des systèmes d'administration transmembranaire de médicament
|
US20120244209A1
(en)
|
2011-03-02 |
2012-09-27 |
Roth Jack A |
Tusc2 therapies
|
CN110464709A
(zh)
|
2012-08-10 |
2019-11-19 |
德克萨斯州大学系统董事会 |
用于治疗中风的神经保护性脂质体组合物和方法
|
WO2015117626A1
(fr)
*
|
2014-02-07 |
2015-08-13 |
Rijksuniversiteit Groningen |
Oligo- et polyaminotétrazoles et leur utilisation dans des agents de contraste irm
|
EP3389650B1
(fr)
|
2015-12-18 |
2022-01-12 |
The Board of Regents of The University of Texas System |
Thérapeutiques pour la prise en charge du travail prématuré
|
AU2017342364B2
(en)
|
2016-10-12 |
2022-12-15 |
Board Of Regents, The University Of Texas System |
Methods and compositions for TUSC2 immunotherapy
|
CN114642720A
(zh)
|
2018-03-23 |
2022-06-21 |
百祥制药公司 |
皂化蛋白c药物组合物和治疗癌症的方法
|
CA3175301A1
(fr)
|
2020-04-20 |
2021-10-28 |
Hugh D.C. Smyth |
Compositions de poudre seche biologiquement actives et leur procede de fabrication et d'utilisation
|
US20230302154A1
(en)
|
2020-08-19 |
2023-09-28 |
The Board Of Regents Of The University Of Texas System |
Nanodrugs for targeted drug delivery and use thereof
|